Astrana Health Inc (ASTH)

Currency in USD
35.52
-1.16(-3.16%)
Closed·
35.560.00(0.00%)
·
Advertisement
Earnings results expected in 6 days
ASTH is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
34.5736.60
52 wk Range
18.0851.60
Key Statistics
Prev. Close
36.68
Open
36.3
Day's Range
34.57-36.6
52 wk Range
18.08-51.6
Volume
424.86K
Average Volume (3m)
601.35K
1-Year Change
48.8684%
Book Value / Share
17.77
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ASTH Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
49.33
Upside
+38.89%
Members' Sentiments
Bearish
Bullish
ProTips
Net income is expected to grow this year

Astrana Health Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Analyst Ratings

10 Buy
1 Hold
0 Sell
Ratings:
11 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 49.33
(+38.89% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Barclays
Buy50.00+40.77%37.00Upgrade26/05/2026
Truist Securities
Buy47.00+32.32%38.00Maintain14/05/2026
TD Cowen
Buy45.00+26.69%35.00Maintain12/05/2026
Barclays
Hold37.00+4.17%26.00Maintain11/05/2026
Baird
Buy45.00+26.69%40.00Maintain08/05/2026

Astrana Health Inc Earnings Call Summary for Q1/2026

  • Q1 2026 EPS of $0.74 beat forecast by 155%, while revenue of $965.1M exceeded expectations, rising 56% year-over-year on acquisition gains.
  • Adjusted EBITDA surged 82% to $66.3M; free cash flow reached $64.1M with cash position of $478.4M as net leverage fell to 2.3x.
  • Stock jumped 11.49% after-hours to $39.30, near 52-week high, before retreating 1.98% in premarket trading to $38.52.
  • FY2026 guidance: EPS of $2.62, revenue of $3.97B; FY2027: EPS of $3.32, revenue of $4.35B, driven by AI platform and risk contracts.
  • Management highlighted successful Prospect acquisition integration and accelerated deleveraging, targeting net leverage at or below 2.0x by year-end.
Last Updated: 11/05/2026, 21:10
Read Full Transcript

Earnings

Latest Release
07/05/2026
EPS / Forecast
0.74 / 0.29
Revenue / Forecast
965.1M / 951.55M
EPS Revisions
Last 90 days

Compare ASTH to Peers and Sector

Metrics to compare
ASTH
Peers
Sector
Relationship
P/E Ratio
52.9x24.4x−0.3x
PEG Ratio
−3.300.950.00
Price/Book
2.0x3.6x2.6x
Price / LTM Sales
0.5x1.5x3.0x
Upside (Analyst Target)
36.3%14.5%56.6%
Fair Value Upside
Unlock13.9%10.2%Unlock

Astrana Health, Inc., a healthcare management company, provides medical care services in the United States. The company operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. Its physician network includes primary care physicians, specialist physicians and extenders, and hospitalists. The company serves patients primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization; and non-insured patients. The company was formerly known as Apollo Medical Holdings, Inc. and changed its name to Astrana Health, Inc. in February 2024. Astrana Health, Inc. was founded in 1992 and is headquartered in Alhambra, California.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
17.36M38.57%633.96M
Other Institutional Investors
19.59M43.50%715.07M
Public Companies & Retail Investors
8.07M17.93%294.66M
Total
45.02M100.00%1.64B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Allied Physicians of California IPA15.18%6,832,698249,462
BlackRock, Inc.13.69%6,163,727225,038

People Also Watch

93.94
ZBH
-1.07%
113.74
FLEX
+1.64%
31.01
TDC
+1.46%
376.82
CIEN
+1.28%
27.47
GEN
+0.66%

FAQ

What Is the Astrana Health (NASDAQ: ASTH) Share Price Today?

The Astrana Health stock price today is 35.52 USD.

What Stock Exchange Does Astrana Health (ASTH) Trade On?

Astrana Health is listed and trades on the Nasdaq Stock Exchange.

What Is the Ticker (Stock Symbol) for Astrana Health?

The stock symbol (also called a 'ticker') for Astrana Health is "ASTH."

What Is the Current Astrana Health Market Capitalisation?

As of today, Astrana Health (NASDAQ: ASTH) market cap is 1.60B USD.

What Is Astrana Health's (ASTH) Earnings Per Share (TTM)?

The Astrana Health EPS is currently 0.61 (Trailing Twelve Months).

When Is the Next Astrana Health Earnings Date?

Astrana Health's next earnings report will be released on 06/08/2026.

Is ASTH a Buy or Sell From a Technical Analyst Perspective?

Based on today's Astrana Health moving averages and other technical indicators, the daily buy/sell signal for ASTH stock is Strong Sell.

How Many Times Has Astrana Health Stock Split?

Astrana Health has split 1 times. (See the ASTH stock split history page for full effective split date and price information.)

How Many Employees Does Astrana Health Have?

Astrana Health has 3000 employees, based on their latest Companies House report.

What is the current trading status of Astrana Health (NASDAQ: ASTH)?

As of 31/07/2026, Astrana Health (ASTH) is trading at a share price of 35.52 USD, with a previous close of 36.68 USD. The stock has fluctuated within a day range of 34.57 USD to 36.60 USD, while its 52-week range spans from 18.08 USD to 51.60 USD.

What Is Astrana Health (ASTH) Price Target According to Analysts?

The average 12-month price target for Astrana Health is 49.33 USD, with a high estimate of 65 USD and a low estimate of 41 USD. 10 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +38.89% Upside potential.

What Is the ASTH Premarket Price?

ASTH's last pre-market stock price is 37.29 USD. The pre-market share volume is 900.00, and the stock has decreased by 0.61, or 1.66%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.